X-Therma's Latest News
Read the latest news about X-Therma, Cryopreservation and Biopreservation.
Science Chops Alone Don’t Cut It: The Entrepreneurial Growth Struggle
In the eight years since launching X-Therma, we’ve achieved chemistry breakthroughs that we believe will truly propel the field of organ transplant to a new
Next-Generation Cryopreservation Techniques: Improving Cold Chain Management For Regenerative Medicines
Cryopreservation has become a crucial component in realizing the large-scale commercial manufacturing of regenerative medicines, which require unique storage and transport strategies to ensure their
X-Therma FCOI Policy
X-Therma posts our FCOI to meet requirements of our incoming NIH funding. You can read the policy here: XT_FCOI
Next-Generation DMSO-Free & Serum-Free Cryopreservation For Cell And Gene Therapy Manufacturing And Processing
Listen in on this discussion about the latest developments in cryopreservation technologies and how they can revolutionize cell and gene therapy manufacturing, processing, and their
Fixing The Regenerative Medicine Supply Chain
In the past few years, specifically through the COVID-19 pandemic, supply-chain vulnerabilities have become the topic of everyday conversation across all industries— not just among
Next Generation Cryopreservation To Help Advance Cell And Gene Therapies
The world has been waiting for the next scientific breakthrough incryopreservation. Dimethyl sulfoxide (DMSO), a by-product of the wood industry, has been in usesince 1953.
XT-Thrive and X-Therma: Next Generation cryopreservation to help advance Cell and Gene Therapies
The world has been waiting for the next scientific breakthrough in cryopreservation. Dimethyl sulfoxide (DMSO), a by-product of the wood industry, has been in use
X-Therma Completes NSF Program With Flying Colors
X-Therma is proud to announce an important milestone on our journey toward enabling more and better organ transplants and off-the-shelf regenerative medicine therapies: Our company
A Bioinspired And Chemically Defined Alternative To Dimethyl Sulfoxide For The Cryopreservation Of Human Hematopoietic Stem Cells
The cryopreservation of hematopoietic cells using dimethyl sulfoxide (DMSO) and serum is a common procedure used in transplantation. However, DMSO has clinical and biological side effects due to its toxicity, and serum introduces variation and safety risks. Explore the development of a novel class of ice-interactive cryoprotectants inspired by natural antifreeze proteins.
